ciT1zen Science by the(sugar)science’s Podcast

T1D Cutting Edge Research - Episode 45 - The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs; Spurrell et al.

16 min · 29. touko 2026
jakson T1D Cutting Edge Research - Episode 45 - The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs; Spurrell et al. kansikuva

Kuvaus

In the forty-fifth episode of "Type 1 Diabetes: Cutting Edge Research" we discuss the paper The Efficacy and Safety of Teplizumab in the Treatment of Stage 3 Type 1 Diabetes:Review & Meta-Analysis of RCTs. ciT1zen science from the(sugar)science is devoted to helping the entire Type 1 Diabetes (T1D) community become more familiar with cutting edge science happening now. Podcasts and summaries to keep you informed. We curate and share important T1D science that you can understand, follow and enjoy. Please note that podcasts were created with the help of notebookLM.

Kommentit

0

Ole ensimmäinen kommentoija

Rekisteröidy nyt ja liity ciT1zen Science by the(sugar)science’s Podcast-yhteisöön!

Aloita maksutta

14 vrk ilmainen kokeilu

Kokeilun jälkeen 7,99 € / kuukausi. · Peru milloin tahansa.

  • Podimon podcastit
  • 20 kuunteluaikaa / kuukausi
  • Lataa offline-käyttöön

Kaikki jaksot

100 jaksot